Frontier Bio

Hayward, California, Singapore · Biotechnology, research · 12 employees

Frontier Bio leverages organ printing technology that directly supports whole-body replacement initiatives, providing the manufacturing infrastructure to produce replacement organs at scale. Additionally, the bioprinting platform’s tissue engineering capabilities support artificial womb development, creating complex vascular networks and specialized tissues required for external gestation systems.

See plans & pricing → Track Frontier Bio’s funding, hiring, and signals — with verified contacts — on Fundz.